2023-09-08T07:09:36-07:00 2022-12-31 752593210 Sutton Frost Cary LLP 600 Six Flags Dr Suite 600 Arlington TX 76011 990 2022-01-01 273869888 INFUSION ACCESS FOUNDATION INFU 5128511303 3307 NORTHLAND DRIVE 160 AUSTIN TX 78731 CHRIS COUNTS DIR. OF OPERATIONS 2023-09-08 true CHRIS COUNTS 999009999 true Carroll Elizabeth Arnott P01965628 8176498083 2 AAL1 IAL1 FAL1 2022 2023-04-26 12:10:37Z ALICIA BARRON 3307 NORTHLAND DRIVE 160 AUSTIN TX 78731 860364 false X patientaccess.org X 2010 TX INfusion Access Foundation's mission is to improve patient access to office-administered intravenous and injectable medications. 5 4 3 5 0 488688 648486 195000 22382 16878 0 511070 860364 15298 0 301782 256283 0 12537 312484 373007 614266 644588 -103196 215776 1014861 1229123 200499 202 814362 1228921 INfusion Access Foundation's mission is to improve patient access to office-administered intravenous and injectable medications. false false 596460 15298 195000 Infusion Access Foundation provides state and national advocacy efforts regarding reimbursment, patient access and regulatory barriers for office-based infusion centers. The organization maintains email newsletters and other media channels to communicate industry news and advocacy efforts. The organizaton also develops educational tools and resources to support infusion center staff. 596460 true true false false false false false false false false true false false false false false false false false false false false false false false false false true false true false false false false false false false false false false false false false true false false false true 3 0 true 3 true false false false false false false false 0 false false false false false false false X 5 4 false false false false false false false true true false false true true true true true true true true false X X CHRIS COUNTS 5128511303 3307 NORTHLAND DRIVE 160 AUSTIN TX 78731 BRIAN NYQUIST SEC/EXEC. DIR. 10.00 40.00 X X 0 144100 9050 CHRIS COUNTS DIR. OF OPER. 10.00 40.00 X 0 121370 8400 ALICIA BARRON Executive Dir. 40.00 0.00 X 79232 0 0 C BRYAN JOHNSON President 3.00 0.00 X X 0 0 0 KATIE THACKSTON Director 3.00 0.00 X 0 0 0 MARISSA SHACKLETON Director 3.00 0.00 X 0 0 0 CHARLES SCHADEWALD Treasurer 3.00 0.00 X X 0 0 0 79232 265470 17450 0 false true false RATIONAL 360 828 L ST NW 640 WASHINGTON DC 20036 public affairs 160000 1 648486 648486 MEMBERSHIP DUES 541900 195000 195000 195000 16878 16878 0 0 0 0 0 0 0 0 860364 195000 16878 X 15298 15298 0 0 0 79233 71309 3962 3962 0 161407 150109 6456 4842 0 0 15643 14548 626 469 0 1966 1966 5874 5874 0 0 0 317313 313880 3433 8447 6837 1610 438 81 357 13524 10557 2967 0 4834 3894 940 14141 9888 989 3264 0 0 0 0 0 4026 4026 DUES & SUBSCRIPTIONS 1516 1516 EMPLOYMENT COSTS 830 830 Postage and Shipping 59 59 BANK & CREDIT CARD CHARGES 39 39 0 644588 596460 35591 12537 256847 661315 560572 564636 0 0 0 0 194270 0 0 0 8115 8115 0 0 0 0 0 3172 3172 1014861 1229123 1109 202 199390 200499 202 X 814362 1228921 814362 1228921 1014861 1229123 215776 198783 X false false false X 182732 718334 556213 488688 648486 2594453 0 0 182732 718334 556213 488688 648486 2594453 1240590 1353863 73 303 22382 16878 39636 0 2500 7954 5012 15466 2649555 2256774 0.51100 0.47500 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 8115 8115 false LUPUS AND ALLIED DISEASE ASSN PO BOX 170 VERONA NY 13478 161083229 501(C)(3) 10000 0 GENERAL SUPPORT 1 0 false false false false false false false false false BRIAN NYQUIST SEC/EXEC. DIR. 117000 25900 1200 9050 153150 Form 990, Part VI, Section B, Line 11b THE FORM 990 WILL BE PROVIDED TO THE BOARD OF DIRECTORS FOR REVIEW WITHIN FIVE BUSINESS DAYS OF COMPLETION. THE BOARD OF DIRECTORS WILL REVIEW AND PROVIDE FEEDBACK TO THE EXECUTIVE DIRECTOR WITHIN FIVE BUSINESS DAYS OF RECEIPT. UPON APPROVAL, THE FORM 990 WILL BE FILED WITHIN FIVE BUSINESS DAYS. Form 990, Part VI, Section B, Line 12c Officers, directors, and employees are informed of their Duty to Disclose in accordance with the organizational Conflicts of Interest Policy during the onboarding process and annually thereafter. After disclosure, the governing board shall discuss and determine if a conflict of interest is present. Upon determination by the governing board that a violation of the Conflicts of Interest Policy has occurred, it shall take appropriate disciplinary and corrective action. Form 990, Part VI, Section B, Line 15a Compensation of the CEO and Executive Director is determined by the Board of Directors, the review and approval of which is documented. Form 990, Part VI, Section B, Line 15b Compensation of other officers and other key employees is determined by the Board of Directors, the review and approval of which is documented. Form 990, Part VI, Section C, Line 18 UPON REQUEST. Form 990, Part VI, Section C, Line 19 Certain documents, including governing documents, conflict of interest policy and financial statements, may be made available upon request at the Boards discretion. NATIONAL INFUSION CENTER ASSOC 3307 NORTHLAND DRIVE 160 AUSTIN TX 78731 845142177 INFUSION PROVIDER TRADE ASSOCIATION TX 501(C)(6) N/A false false false false false false false false false false false false false false true true false false false false